Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05117541 · ClinicalTrials.gov registry record
Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection
A clinical trial of Hepatitis B Infection and Chronic Viral Hepatitis, sponsored by Thomas Jefferson University.
- Active
- Registry status
- 365
- Enrollment target
- 1
- Study location
NCT05117541: Active study of Hepatitis B Infection and Chronic Viral Hepatitis, sponsored by Thomas Jefferson University.
NCT05117541 is a study of Hepatitis B Infection and Chronic Viral Hepatitis that is active but no longer recruiting, run by Thomas Jefferson University. The registered enrollment target is 365 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05117541, a study of Hepatitis B Infection and Chronic Viral Hepatitis, is active but no longer recruiting, sponsored by Thomas Jefferson University.
- ACTIVE NOT RECRUITING
- Registry status
- 365 participants
- Enrollment target
- 1
- Study location
Study Summary
This study explores how psychosocial factors (e.g., chronic stress, depression) may lead to liver disease progression such as liver cirrhosis or liver cancer among Korean American chronic hepatitis B infection patients. Gathering health information over time from Korean Americans with chronic hepatitis B infection may help doctors find better methods of treatment and on-going care.
Primary Outcome
Categorized as follows: 1) immune tolerant, 2) immune active with hepatitis B virus e antigen (HBeAg)(+), 3) immune active with HBeAg(-), and 4) inactive carrier, with patients not fitting into one of these four phenotypes classified as 5) indeterminant. Phenotype at study enrollment will be calculated
Conditions Studied
Interventions
- PROCEDURE Biospecimen Collection
- OTHER Electronic Health Record Review
- OTHER Interview
Study Locations (1)
Pennsylvania
- Thomas Jefferson University Hospital - Philadelphia
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 365 participants |
| Start Date | 2021-08-02 |
| Est. Completion | 2026-03-30 |
What the registry record for NCT05117541 still lists
NCT05117541 is an observational study that tracks outcomes without assigning an intervention. The registered 365 participants enrollment target is mid-sized for trials with a published cap.
The record links to 2 conditions, with Hepatitis B Infection appearing as the primary indexed condition, and to 3 interventions - of which Biospecimen Collection is the first listed.
NCT05117541 reports a single indexed study location in Pennsylvania.
Frequently Asked Questions
What is clinical trial NCT05117541 about?
NCT05117541 is a clinical study titled "Social-environmental, Psychosocial, Behavioral, Clinical and Biological Drivers of Disparities in Liver Disease Progression Among Korean American With Chronic Hepatitis B Infection". This study explores how psychosocial factors (e.g., chronic stress, depression) may lead to liver disease progression such as liver cirrhosis or liver cancer among Korean American chronic hepatitis B infection patients. Gathering health information over time from Korean Americans with chronic hepati...
What is the current status of trial NCT05117541?
This trial is currently active not recruiting. The enrollment target is 365 participants. The study started on 2021-08-02. Estimated completion is 2026-03-30.
What conditions does trial NCT05117541 study?
This clinical trial studies the following conditions: Hepatitis B Infection, Chronic Viral Hepatitis.
What interventions are being tested in trial NCT05117541?
The interventions under investigation include: Biospecimen Collection (PROCEDURE), Electronic Health Record Review (OTHER), Interview (OTHER).
Who is sponsoring clinical trial NCT05117541?
This trial is sponsored by Thomas Jefferson University, which has 292 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05117541 being conducted?
This trial has 1 study location across Pennsylvania. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Hepatitis B Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04049604 · 365 participants · NA
IDENTIFY Study: Natural History of Maternal Neoplasia
- NCT05065840 · 365 participants · NA
Advancing HPV Vaccination Among HIV Positive Adults: The CHAMPS Study
- NCT05303519 · 365 participants · Phase 3
SIGMA (Safusidenib in IDH1 Mutant Glioma Maintenance)
- NCT05592626 · 365 participants · Phase 1
A Study of a Selective T Cell Receptor (TCR) Targeting, Bifunctional Antibody-fusion Molecule STAR0602 in Participants With Advanced Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI